![Octahydro-1H-cyclopenta[c]pyridine](https://static.cymitquimica.com/cas-image/586916-octahydro-1h-cyclopenta-c-pyridine.png)
CAS: 54152-52-2 - Octahydro-1H-cyclopenta[c]pyridine
Fórmula:C8H15N
InChI:InChI=1S/C8H15N/c1-2-7-4-5-9-6-8(7)3-1/h7-9H,1-6H2
Chave InChI:InChIKey=KPXSPHQLZBMRLW-UHFFFAOYSA-N
SMILES:N1CCC2CCCC2C1
- Sinónimos:
- 1H-Cyclopenta[c]pyridine, octahydro-
- 2,3,4,4a,5,6,7,7a-Octahydro-1H-cyclopenta[c]pyridine
- 1H-2-Pyrindine, octahydro-
- Octahydro-1H-cyclopenta[c]pyridine
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 2,3,4,4a,5,6,7,7a-octahydro-1H-cyclopenta[c]pyridine REF: IN-DA00I9O1CAS: 54152-52-2 | - - - | A consultar | Qua 02 Out 24 |
 | Octahydro-1H-cyclopenta[c]pyridine REF: 10-F602249CAS: 54152-52-2 | 97% | A consultar | Ter 15 Out 24 |
 | Octahydro-1H-cyclopenta[C]pyridine REF: 3D-ECA15252CAS: 54152-52-2 | Min. 95% | A consultar | Qua 13 Nov 24 |
![2,3,4,4a,5,6,7,7a-octahydro-1H-cyclopenta[c]pyridine](https://static.cymitquimica.com/products/IN/thumb/DA00I9O1.jpg)
2,3,4,4a,5,6,7,7a-octahydro-1H-cyclopenta[c]pyridine
CAS:54152-52-2
Fórmula:
C8H15N
Peso molecular:
125.2114
Ref: IN-DA00I9O1
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Quarta-feira 2 de Outubro de 2024
![Octahydro-1H-cyclopenta[c]pyridine](https://static.cymitquimica.com/products/10/thumb/F602249.jpg)
Ref: 10-F602249
| 1g | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 15 de Outubro de 2024
![Octahydro-1H-cyclopenta[C]pyridine](https://static.cymitquimica.com/products/3D/thumb/ECA15252.jpg)
Octahydro-1H-cyclopenta[C]pyridine
CAS:54152-52-2
Octahydro-1H-cyclopenta[C]pyridine is a thrombin receptor antagonist that inhibits platelet activation. It has been used clinically …
Fórmula:
C8H15N
Pureza:
Min. 95%
Peso molecular:
125.21 g/mol
Ref: 3D-ECA15252
| 25mg | A consultar | ||
| 250mg | A consultar |
Entrega estimada em Estados Unidos, Quarta-feira 13 de Novembro de 2024
